Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Physicians can be considered medical artists, so Australian scientists are developing an advanced "paintbrush" for surgeons specializing in arthritis and joint replacements.
Tetraspanin-7 has been identified as the fifth target attacked by the immune system in patients with type 1 diabetes. Scientists have been aware of the first four immune…
The surgeons of tomorrow, along with anyone who might have been interested, were recently invited to experience the world's first live operation filmed in 360-degree VR.
Convincing patients to routinely check their blood-sugar is sometimes an uphill battle. In this video, Jane Seley, a certified diabetes educator (CDE) and diabetes nurse practitioner (DNP), shares…
Using a motor cortex implant, a series of electrode-lined bracelets, and sophisticated software, this paralyzed patient temporarily regained some use of his wrists and hands.
On April 8, 2016, the FDA updated labeling recommendations for metformin and metformin-containing drugs, expanding the indication(s) to include treatment for type 2 diabetes patients with mild-to-moderate renal…
A new method of coaxing adult cells into iMS cells may be safer, more versatile, and more effective than current, experimental embryonic stem cell processes.
